实体
Rendu Bio
Rendu Bio
PulseAugur coverage of Rendu Bio — every cluster mentioning Rendu Bio across labs, papers, and developer communities, ranked by signal.
总计 · 30天
2
90 天内 2
发布 · 30天
0
90 天内 0
论文 · 30天
0
90 天内 0
层级分布 · 90 天
时间线
- 2026-05-14 funding RenDu Bio's controlling shareholder is changing to Nanjing Haijing Pharmaceutical through a share transfer agreement. 来源
情绪 · 30 天
1 天有情绪数据
最近 · 第 1/1 页 · 共 2 条
-
RenDu Bio's controlling shareholder to change to Haijing Pharmaceutical
RenDu Bio announced that its controlling shareholder, Jinliang Ju, and others will transfer approximately 8.52 million shares to Nanjing Haijing Pharmaceutical for about 516 million yuan. Following this transaction, Hai…
-
益明医药股东计划减持1%
益明医药宣布，股东周展计划减持不超过公司总股本1%的股份。另外，仁度生物宣布，其控股股东及实际控制人朱金亮等股东计划进行股权转让，可能导致公司控制权发生变更，已停牌。此外，小米手机出货量跌出前五，其汽车业务可能是原因之一。